Mendoza-Lattes Sergio, Weiss Andrew, Found Ernest, Zimmerman Bridget, Gao Yubo
Department of Orthopaedics and Rehabilitation, College of Public Health, The University of Iowa, IA, USA.
Iowa Orthop J. 2009;29:91-6.
Retrospective case-control study.
To compare the effectiveness between caudal and trans-foraminal epidural steroid injections for the treatment of primary lumbar radiculopathy.
Spinal injections with steroids play an important role in non-operative care of lumbar radiculopathy. The trans-foraminal epidural steroid injection (TESI) theoretically has a higher success rate based on targeted delivery to the symptomatic nerve root. To our knowledge, these results have not been compared with other techniques of epidural steroid injection.
93 patients diagnosed with primary lumbar radiculopathy of L4, L5, or SI were recruited for this study: 39 received caudal epidural steroid injections (ESI) and 54 received trans-foraminal epidural steroid injections (TESI). Outcomes scores included the SF-36, Oswestry disability index (ODI) and pain visual analogue scale (VAS), and were recorded at baseline, post-treatment (<6 months), long-term (>1 year). The average follow-up was 2 years, and 16 patients were lost to follow-up. The endpoint "surgical intervention" was a patient-driven decision, and considered failure of treatment. Intent-to-treat analysis, and comparisons included t-test, Chi-square, and Wilcoxon rank-sum test.
Baseline demographics and outcomes scores were comparable for both treatment groups (ESI vs. TESI): (SF-36 PCS (32.3 +/- 7.5 vs. 29.5 +/- 8.9 respectively; p = 0.173), MCS (41.2 +/- 12.7 vs. 41.1 +/- 10.9, respectively; p = 0.971), and VAS (7.4 +/-2.1 vs. 7.9 +/- 1.2, respectively; p = 0.228)). Surgery was indicated for failure of treatment at a similar rate for both groups (41.0% vs. 44.4%, p=0.743). Symptom improvement was comparable between both treatment groups (ESI vs. TESI): SF-36 PCS improved to 42.0+/-11.8 and 37.7+/-12.3, respectively; p=0.49; ODI improved from 50.0+/-21.2 to 15.6+/-17.9and from 62.1+/-17.9 to 26.1+/-20.3, respectively (p=0.407).
The effectiveness of TESI is comparable to that of ESI (approximately 60%) for the treatment of primary lumbar radiculopathy. The increased complexity of TESI is not justified for primary cases, and may have a more specific role in recurrent disease or for diagnostic purposes.
回顾性病例对照研究。
比较骶管和经椎间孔硬膜外类固醇注射治疗原发性腰椎神经根病的疗效。
类固醇脊髓注射在腰椎神经根病的非手术治疗中起重要作用。经椎间孔硬膜外类固醇注射(TESI)理论上基于对症状性神经根的靶向给药成功率更高。据我们所知,这些结果尚未与其他硬膜外类固醇注射技术进行比较。
本研究招募了93例诊断为L4、L5或S1原发性腰椎神经根病的患者:39例接受骶管硬膜外类固醇注射(ESI),54例接受经椎间孔硬膜外类固醇注射(TESI)。结果评分包括SF-36、Oswestry功能障碍指数(ODI)和疼痛视觉模拟量表(VAS),并在基线、治疗后(<6个月)、长期(>1年)记录。平均随访2年,16例患者失访。终点“手术干预”是患者驱动的决定,并被视为治疗失败。意向性分析,比较包括t检验、卡方检验和Wilcoxon秩和检验。
两个治疗组(ESI与TESI)的基线人口统计学和结果评分具有可比性:(SF-36身体功能评分(PCS)分别为32.3±7.5和29.5±8.9;p = 0.173),心理功能评分(MCS)分别为41.2±12.7和41.1±10.9(p = 0.971),以及VAS分别为7.4±2.1和7.9±1.2(p = 0.228))。两组因治疗失败而进行手术的比例相似(41.0%对44.4%,p = 0.743)。两个治疗组(ESI与TESI)之间的症状改善具有可比性:SF-36 PCS分别改善至42.0±11.8和37.7±12.3;p = 0.49;ODI分别从50.0±21.2改善至15.6±17.9以及从62.1±17.9改善至26.1±20.3(p = 0.407)。
对于原发性腰椎神经根病的治疗,经椎间孔硬膜外类固醇注射(TESI)的疗效与骶管硬膜外类固醇注射(ESI)相当(约60%)。经椎间孔硬膜外类固醇注射(TESI)增加的复杂性对于原发性病例没有合理性,可能在复发性疾病或诊断目的方面具有更特定的作用。